MiR-155 promotes compensatory lung growth by inhibiting JARID2 activation of CD34+ endothelial progenitor cells

PLoS One. 2024 Feb 23;19(2):e0296671. doi: 10.1371/journal.pone.0296671. eCollection 2024.

Abstract

Bone marrow-derived CD34-positive (CD34+) endothelial progenitor cells (EPCs) has unique functions in the mechanism of compensatory lung growth (CLG). The content of this study is mainly to describe the effect of microRNA (miR)-155 in the mechanisms of EPCs and CLG. Our study found that transfection of miR-155 mimic could promote EPC proliferation, migration and tube formation, while transfection of miR-155 inhibitor had the opposite effect. It was also found that transfection of pc-JARID2 inhibited EPC proliferation, migration and tube formation, while transfection of si-JARID2 had the opposite effect. miR-155 can target and negatively regulate JARID2 expression. Overexpression of JARID2 weakened the promoting effects of miR-155 mimic on EPC proliferation, migration, and tubular formation, while silencing JARID2 weakened the inhibitory effects of miR-155 inhibitors on EPC proliferation, migration, and tubular formation. Transplantation of EPCs transfected with miR-155 mimic into the left lung model effectively increased lung volume, total alveolar number, diaphragm surface area, and lung endothelial cell number, while transplantation of EPCs co-transfected with miR-155 mimic and pc-JARID2 reversed this phenomenon. Overall, we found that miR-155 activates CD34+ EPC by targeting negative regulation of JARID2 and promotes CLG.

MeSH terms

  • Animals
  • Antigens, CD34 / metabolism
  • Cell Movement
  • Cell Proliferation
  • Endothelial Progenitor Cells* / metabolism
  • Lung* / metabolism
  • Mice
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Polycomb Repressive Complex 2 / metabolism

Substances

  • Antigens, CD34
  • MicroRNAs
  • Mirn155 microRNA, mouse
  • Jarid2 protein, mouse
  • Polycomb Repressive Complex 2

Grants and funding

This study was supported by Yunnan Provincial Science and Technology Department-Kunming Medical University (Grant No.202201AY070001-137); Joint Special Fund for Applied Basic Research of Yunnan Provincial Science and Technology Department-Kunming Medical University (No. 202101AY070001-170, No. 202301AY070001-085).